Concert Pharma (CNCE) Misses Q1 EPS by 12c
Get Alerts CNCE Hot Sheet
Join SI Premium – FREE
Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($1.03), $0.12 worse than the analyst estimate of ($0.91).
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
- Home Bancshares (HOMB) Tops Q1 EPS by 3c
- Elevance Health (ELV) hikes 2024 earnings outlook, shares climb
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!